Your session is about to expire
← Back to Search
Feeding Practices for Premature Infants
N/A
Recruiting
Led By Rajeev Kumar, MD
Research Sponsored by Rajeev Kumar
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Preterm Infants 24-34 weeks of gestation
On Non-invasive ventilation (NIPPV/CPAP/HFNC)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the date of randomization until the date of nicu discharge/death, assessed up to 1 year.
Awards & highlights
Study Summary
This trial compares two methods of feeding preterm babies on non-invasive respiratory support to see which is faster to reach full feeds.
Who is the study for?
This trial is for preterm infants between 24-34 weeks of gestation who are not eating by mouth or only receiving minimal feeds and require non-invasive breathing support. Infants with major birth defects, those on invasive ventilation, or older than 34 weeks gestational age cannot participate.Check my eligibility
What is being tested?
The study aims to determine the best feeding method for premature babies needing respiratory support. It compares two approaches: giving food in small amounts at intervals (intermittent bolus feeds) versus a steady flow of nutrition (continuous feeds).See study design
What are the potential side effects?
While the trial focuses on feeding practices rather than medications, potential side effects may include digestive issues such as intolerance to feedings, abdominal distension, or complications related to their prematurity and respiratory status.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My baby was born between 24 and 34 weeks of pregnancy.
Select...
I am using a machine to help with my breathing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the date of randomization until the date of nicu discharge/death, assessed up to 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the date of randomization until the date of nicu discharge/death, assessed up to 1 year.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Day of life to reach full feeds
Secondary outcome measures
Feeding interruptions
Length of hospital stay
Time to reach (day of life) first oral feed
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Continuous FeedingExperimental Treatment1 Intervention
Continuous feeding will be defined as delivering enteral nutrition with constant speed for 24 hours via a nutritional pump.
It will be further stratified as per weight ( less than 1000 g, 1000-1500 g, >1500 g).
Group II: Bolus FeedingExperimental Treatment1 Intervention
Intermittent bolus feeding will be defined as delivering enteral nutrition multiple times, usually every 2-3 hours over 15 - 30 minutes by gravity or an electric pump.
It will be further stratified as per weight ( less than 1000 g, 1000-1500 g, >1500 g).
Find a Location
Who is running the clinical trial?
Rajeev KumarLead Sponsor
Rajeev Kumar, MDPrincipal InvestigatorCook County Health
2 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My baby was born between 24 and 34 weeks of pregnancy.My infant is on a ventilator or nasal cannula and is being fed more than minimal amounts.You were born with major physical abnormalities.You are more than 34 weeks pregnant.I am using a machine to help with my breathing.
Research Study Groups:
This trial has the following groups:- Group 1: Bolus Feeding
- Group 2: Continuous Feeding
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there vacancies available in this experiment for prospective participants?
"This experiment, which was first launched on February 1st 2023, is currently enrolling patients. Clinicaltrials.gov indicates that the data concerning this study was most recently amended on April 11th 2023."
Answered by AI
What would be the uppermost limit of participants in this trial?
"Affirmative. On clinicaltrials.gov, the evidence suggests that this medical trial is currently seeking participants. It opened for recruitment on February 1st 2023 and was last updated on April 11th of the same year; its intent is to enrol 46 patients at a single location."
Answered by AI
Share this study with friends
Copy Link
Messenger